Affluent Medical SAS
Affluent Medical SA, a medical technology company, develops and markets minimally invasive minimally invasive medical devices in the field of urology and structural heart in France. It offers Artus, an implantable electro-mechanical artificial sphincter that targets moderate to severe urinary incontinence; and Kalios and Epygon implants for the treatment of mitral insufficiency, as well as Kardio… Read more
Affluent Medical SAS (AFME) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: -0.319x
Based on the latest financial reports, Affluent Medical SAS (AFME) has a cash flow conversion efficiency ratio of -0.319x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-6.74 Million) by net assets (€21.11 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Affluent Medical SAS - Cash Flow Conversion Efficiency Trend (2016–2024)
This chart illustrates how Affluent Medical SAS's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Affluent Medical SAS Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Affluent Medical SAS ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
VISIOMED GROUP EO 001
F:7V91
|
N/A |
|
EnviroGold Global Limited
OTCQB:ESGLF
|
-0.151x |
|
Sea Oil Public Company Limited
BK:SEAOIL
|
0.017x |
|
Loulis Mills S.A.
AT:KYLO
|
0.049x |
|
9M00
F:9M00
|
0.342x |
|
AfriTin Mining Limited
PINK:AFTTF
|
-0.059x |
|
Precipio Inc
NASDAQ:PRPO
|
0.001x |
|
Maxiparts Ltd
AU:MXI
|
0.065x |
Annual Cash Flow Conversion Efficiency for Affluent Medical SAS (2016–2024)
The table below shows the annual cash flow conversion efficiency of Affluent Medical SAS from 2016 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | €30.27 Million | €-11.32 Million | -0.374x | +2.33% |
| 2023-12-31 | €31.47 Million | €-12.05 Million | -0.383x | -16.94% |
| 2022-12-31 | €33.83 Million | €-11.08 Million | -0.328x | -15.33% |
| 2021-12-31 | €43.53 Million | €-12.36 Million | -0.284x | -12.16% |
| 2020-12-31 | €35.29 Million | €-8.94 Million | -0.253x | +35.66% |
| 2019-12-31 | €30.96 Million | €-12.19 Million | -0.394x | -122.87% |
| 2017-12-31 | €61.39 Million | €-10.84 Million | -0.177x | +4.12% |
| 2016-12-31 | €58.87 Million | €-10.84 Million | -0.184x | -- |